Stock Comparison

SRPT vs UNH

Sarepta Therapeutics Inc vs UnitedHealth Group Inc

The Verdict

SRPT takes this one.

Winner

SRPT

Sarepta Therapeutics Inc

6.8

out of 10

Solid Pick

UNH

UnitedHealth Group Inc

0.3

out of 10

Distressed

Head-to-Head

$1.9B

Market Cap

$365.5B

29.0

P/E Ratio

30.3

3.0%

Profit Margin

2.7%

4.9%

Return on Equity

12.4%

0.7

Debt-to-Equity

0.8

Moderate

Overall Risk

Moderate

6.8

DVR Score

0.3

The Deep Dive

SRPT6.8/10

Score Change Explanation: The previous analysis (2026-04-05) highlighted "persistent commercial execution issues for Elevidys, reflected in Q4 2025's wider-than-expected loss and reduced 2026 revenue guidance." The Q1 2026 earnings, reported on May 6, 2026, represent a material positive change. Sarepta reported a significant swing to GAAP operating income of $358.4 million and GAAP net income of $...

Full SRPT Analysis

UNH0.3/10

UnitedHealth Group (UNH) remains a robust, high-quality mega-cap in the mature and highly regulated healthcare sector. Q1 2026 adjusted EPS of $7.23, a recent dividend increase to $2.32, and some analyst upgrades (e.g., Truist to $440, Goldman Sachs Conviction Buy) reflect solid operational performance and financial strength. However, these are characteristics of a stable compounder, not a company...

Full UNH Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.